Back

Results - Announcements

Sales decline 15.60% to Rs 7.09 crore

Eiko Lifesciences standalone net profit rises 190.32% in the March 2025 quarter

15-May-2025, 07:39
Net profit of Eiko Lifesciences rose 190.32% to Rs 0.90 crore in the quarter ended March 2025 as against Rs 0.31 crore during the previous quarter ended March 2024. Sales declined 15.60% to Rs 7.09 crore in the quarter ended March 2025 as against Rs 8.40 crore during the previous quarter ended March 2024.

For the full year,net profit rose 132.00% to Rs 1.74 crore in the year ended March 2025 as against Rs 0.75 crore during the previous year ended March 2024. Sales rose 16.33% to Rs 32.49 crore in the year ended March 2025 as against Rs 27.93 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	7.09	8.40	-16	32.49	27.93	16
OPM %	7.33	6.07	-	5.23	5.73	-
PBDT	1.01	0.60	68	2.60	1.64	59
PBT	0.86	0.42	105	1.97	0.98	101
NP	0.90	0.31	190	1.74	0.75	132